🧬 ctDNA making progress to evaluate cancer recurrence for Stage II and Stage III non seminoma germ cell tumors #GU24 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Nabil Adra IU Simon Comprehensive Cancer Center Jennifer King Clint Cary, MD MPH MBA Rebecca Hassoun Tareq Salous

Phenomenal work by Rebecca Hassoun showing ctDNA monitoring can be used as a predictive biomarker for recurrence in non-seminomatous GCT! ASCO #GU24 OncoAlert OncLive.com

Honored to have had the opportunity to present our work! Grateful for the mentorship of Nabil Adra Jennifer King Tareq Salous

Survivorship matters. Today our excellent phd student Zuzana Országhová drew much attention ASCO genitourinary cancers symposium. Important data from our unique #testicularcancer survivorship database from #Slovakia

Congratulations to post-doc and medical fellows IU School of Medicine, Pamela Mendoza-Munoz, Subramanyam Dasari, and Rebecca Hassoun, who were selected for oral presentations from 170 submitted abstracts during #CancerResearchDay. #ResearchCuresCancer

Patients with relapsed germ cell tumors with progressive brain metastases are curable with multimodal therapy which includes high-dose chemotherapy + SCT. Aggressive and efficient management of these patients can alter outcomes. Jennifer King IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship #ASCO24

ctDNA promising in diagnosis, on-treatment monitoring, and MRD evaluation in patients with germ-cell tumor. Larger studies needed to validate. Alex Chehrazi-Raffle, MD Dr. John Sfakianos IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship Rebecca Hassoun #ASCO24 Testicular Cancer Indiana University Department of Urology

🚀 Brilliant poster presentation by Rebecca Hassoun on longitudinal evaluation of ctNA as a prognostic biomarker to detect minimal residual disease in testicular cancer #ASCO24 ‼️ ASCO ASCO TECAG OncoAlert

Nabil Adra (Nabil Adra), MD, was recently named to IBJ News' Forty Under 40 with nominations from his mentor Larry Einhorn, MD, and other colleagues at IU School of Medicine. Learn more: ow.ly/LC3u50RZ9Ig. #ResearchCuresCancer

In 1974, the survival rate for testicular cancer was just 5%. Today, thanks to the groundbreaking work of Lawrence Einhorn, MD, at IU Simon Comprehensive Cancer Center, that number has soared to more than 95%. Join us in celebrating 50 years of transformative research: ow.ly/Fvto50Tpzw6.

In 1974, Dr. Larry Einhorn, a young oncologist at Indiana University, had an idea that would go on to save hundreds of thousands of lives. If Dr. Einhorn has touched your life, help us say “thank you” by submitting a video or note of gratitude by Oct. 28: ow.ly/yrjM50TCK2C.

Standing room only for GCT session. Happy to see the enthusiasm to review new data and trial landscape. Time to finish the mission in testes/GCT! Great talks by Axel Heidenreich, Nabil Adra and Dr. Darren Feldman #GU25

Neuropathy, rash, or hyperglycemia associated with improved PFS in UC pts treated with EV. Tareq Salous #GU25 IU Simon Comprehensive Cancer Center Rebecca Hassoun Stephanie Schneck Jennifer King Noah Richardson

Extended interval dosing of denosumab in metastatic prostate ca not associated with increased skeletal events. Data from GU pharmD Stephanie Schneck from IU Simon Comprehensive Cancer Center Jennifer King Tareq Salous Noah Richardson #GU25

Xerostomia and ocular dryness predicted PSA response in pts with metastatic prostate ca treated with PSMA Lu177. Data from GU post doc Rebecca Hassoun IU Simon Comprehensive Cancer Center Jennifer King Tareq Salous Noah Richardson Stephanie Schneck #GU25

Fortunate to work with an incredible team! IU group at GU ASCO Clint Cary, MD MPH MBA Jennifer King Tareq Salous Stephanie Schneck IU Simon Comprehensive Cancer Center Indiana University Department of Urology IU_UroOnc Rebecca Hassoun Ahmed Bilal Khalid Noah Richardson #GU25

Welcome to the newest members of the OSU IM family!! Introducing the class of 2028 😎🎉

Live from #ASCO25! Our researchers are sharing their latest work and standing proudly by their posters today in Chicago. From lab discoveries to clinical impact, they’re driving cancer research forward. #ResearchCuresCancer ASCO

Dr. Rebecca Hassoun presenting outcomes with salvage high dose chemo and transplant in relapsed GCT based on radiographic vs tumor marker progression Rebecca Hassoun IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship

Tour de force by Larry Einhorn going over Pitfalls in the Management of Metastatic GCT and wisdom from over 50 years of expertise in treating testicular cancer. And yes the reference for hCG decline was from Robin Zon, MD, FACP, FASCO from IU fellowship IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship Indiana University Department of Urology